Lipopolysaccharide-activated microglia lower P-glycoprotein function in brain microvascular endothelial cells

Neuroscience Letters

Volumn 524, Issue 1, 2012, Pages 45-48

  Matsumoto, Junichi ^a   Dohgu, Shinya ^a   Takata, Fuyuko ^a,b   Nishioku, Tsuyoshi ^a   Sumi, Noriko ^a   Machida, Takashi ^a   Takahashi, Hiroyuki ^a   Yamauchi, Atsushi ^a   Kataoka, Yasufumi ^a,b  

^a FUKUOKA UNIVERSITY   (Japan)

^b PharmaCo Cell Co Ltd   (Japan)

Author keywords

Blood brain barrier; Brain endothelial cell; Lipopolysaccharide; Microglia; NADPH oxidase; P glycoprotein

Indexed keywords

DIPHENYLIODONIUM SALT; GLYCOPROTEIN P; LIPOPOLYSACCHARIDE; RHODAMINE 123;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; COCULTURE; CONTROLLED STUDY; MICROGLIA; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; LIPOPOLYSACCHARIDES; MICROGLIA; MICROVESSELS; NADPH OXIDASE; ONIUM COMPOUNDS; P-GLYCOPROTEIN; RATS; RATS, WISTAR; RHODAMINE 123;

EID: 84864575300     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.07.004     Document Type: Article

References (24)

1. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience 2006, 7:41-53.
2. Bauer B., Hartz A.M., Miller D.S. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Molecular Pharmacology 2007, 71:667-675.
3. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
4. Dohgu S., Takata F., Matsumoto J., Oda M., Harada E., Watanabe T., Nishioku T., Shuto H., Yamauchi A., Kataoka Y. Autocrine and paracrine up-regulation of blood-brain barrier function by plasminogen activator inhibitor-1. Microvascular Research 2011, 81:103-107.
5. Fontaine M., Elmquist W.F., Miller D.W. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sciences 1996, 59:1521-1531.
6. Hartz A.M., Bauer B., Fricker G., Miller D.S. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Molecular Pharmacology 2006, 69:462-470.
7. Hembury A., Mabondzo A. Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier. Cellular and Molecular Neurobiology 2008, 28:915-921.
8. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathologica 2003, 106:518-526.
9. Kortekaas R., Leenders K.L., van Oostrom J.C., Vaalburg W., Bart J., Willemsen A.T., Hendrikse N.H. Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo. Annals of Neurology 2005, 57:176-179.
10. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 1996, 19:312-318.
11. Miller D.S., Bauer B., Hartz A.M. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacological Reviews 2008, 60:196-209.
12. Nishioku T., Hashimoto K., Yamashita K., Liou S.Y., Kagamiishi Y., Maegawa H., Katsube N., Peters C., von Figura K., Saftig P., Katunuma N., Yamamoto K., Nakanishi H. Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. Journal of Biological Chemistry 2002, 277:4816-4822.
13. Nishioku T., Dohgu S., Takata F., Eto T., Ishikawa N., Kodama K.B., Nakagawa S., Yamauchi A., Kataoka Y. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cellular and Molecular Neurobiology 2009, 29:309-316.
14. Nishioku T., Matsumoto J., Dohgu S., Sumi N., Miyao K., Takata F., Shuto H., Yamauchi A., Kataoka Y. Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. Journal of Pharmacological Science 2010, 112:251-254.
15. Pei Z., Pang H., Qian L., Yang S., Wang T., Zhang W., Wu X., Dallas S., Wilson B., Reece J.M., Miller D.S., Hong J.S., Block M.L. MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity. Glia 2007, 55:1362-1373.
16. Qian L., Gao X., Pei Z., Wu X., Block M., Wilson B., Hong J.S., Flood P.M. NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. Parkinsonism Related Disorder 2007, 13(Suppl. 3):S316-S320.
17. Salkeni M.A., Lynch J.L., Otamis-Price T., Banks W.A. Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways. Journal of Neuroimmune Pharmacology 2009, 4:276-282.
18. Schreibelt G., Kooij G., Reijerkerk A., van Doorn R., Gringhuis S.I., van der Pol S., Weksler B.B., Romero I.A., Couraud P.O., Piontek J., Blasig I.E., Dijkstra C.D., Ronken E., de Vries H.E. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB Journal 2007, 21:3666-3676.
19. Sumi N., Nishioku T., Takata F., Matsumoto J., Watanabe T., Shuto H., Yamauchi A., Dohgu S., Kataoka Y. Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cellular and Molecular Neurobiology 2010, 30:247-253.
20. Tai L.M., Loughlin A.J., Male D.K., Romero I.A. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. Journal of Cerebral Blood Flow and Metabolism 2009, 29:1079-1083.
21. Takata F., Dohgu S., Matsumoto J., Takahashi H., Machida T., Wakigawa T., Harada E., Miyaji H., Koga M., Nishioku T., Yamauchi A., Kataoka Y. Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro. Journal of Neuroinflammation 2011, 8:106.
22. van Assema D.M., Lubberink M., Bauer M., van der Flier W.M., Schuit R.C., Windhorst A.D., Comans E.F., Hoetjes N.J., Tolboom N., Langer O., Müller M., Scheltens P., Lammertsma A.A., van Berckel B.N. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain 2012, 135:181-189.
23. Yamauchi A., Dohgu S., Nishioku T., Shuto H., Naito M., Tsuruo T., Sawada Y., Kataoka Y. An inhibitory role of nitric oxide in the dynamic regulation of the blood-brain barrier function. Cellular and Molecular Neurobiology 2007, 27:263-270.
24. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature Reviews Neuroscience 2011, 12:723-738.